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Available online 19 February 2008The structural complexity of the cell membrane makes analysis of membrane processes in living cells, as
compared to model membrane systems, highly challenging. Living cells decorated with surface-attached
colorimetric/ﬂuorescent polydiacetylene patches might constitute an effective platform for analysis and
visualization of membrane processes in situ. This work examines the biological and chemical consequences of
plasma membrane labeling of promyelocytic leukemia cells with polydiacetylene. We show that the extent of
fusion between incubated lipid/diacetylene vesicles and the plasma membrane is closely dependent upon the
lipid composition of both vesicles and cell membrane. In particular, we ﬁnd that cholesterol presence
increased bilayer fusion between the chromatic vesicles and the plasma membrane, suggesting that
membrane organization plays a signiﬁcant role in the fusion process. Spectroscopic data and physiological
assays show that decorating the cell membrane with the lipid/diacetylene patches reduces the overall lateral
diffusionwithin the membrane bilayer, however polydiacetylene labeling does not adversely affect important
cellular metabolic pathways. Overall, the experimental data indicate that the viability and physiological
integrity of the surface-engineered cells are retained, making possible utilization of the platform for studying
membrane processes in living cells. We demonstrate the use of the polydiacetylene-labeled cells for
visualizing and discriminating among different membrane interaction mechanisms of pharmaceutical
compounds.
© 2008 Elsevier B.V. All rights reserved.Keywords:
Plasma membrane
Membrane sensor
Lipid fusion
Polydiacetylene
Membrane permeation
FRET
Biomimetic chemistry1. Introduction
The plasma membrane constitutes the platform for fundamental
biological processes, such as ligand recognition [1], drug action [2],
vesicle fusion and endocytosis [3], pore-formation by membrane-
active peptides [4], and others. Numerous studies of membrane
properties and membrane-associated processes have been reported,
primarily through the use of varied model systems, such as vesicles,
lipid monolayers and ﬁlms, multilamellar systems, artiﬁcial lipid72 8 6472943.
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l rights reserved.bilayers, and others. There are naturally clear advantages in the
analysis of membrane events in the real molecular environments of
living cells, rather than model membrane systems. The plasma mem-
brane, however, is a highly complex biological entity, posing consider-
able challenges for application of bioanalytical techniques to elucidate
detailed and speciﬁc molecular aspects. While many ﬂuorescent
probes (both small ﬂuorescent dyes as well as large biological macro-
molecules) have been used for imaging cellular membranes [5],
structural or dynamical analyses of membrane processes in living cells
have been rare. Recently we have demonstrated that cells labeled with
chromatic polydiacetylene (PDA) patches constitute a useful platform
for studying varied membrane events in live cells [6,7].
Membrane labeling of living cells with PDA facilitates exploitation
of the unique chromatic properties of this conjugated polymer [8].
PDA-based vesicles and thinﬁlms have been shown toundergo distinct
blue–red colorimetric changes owing to conformational transitions in
the conjugated (ene–yne) polymer backbone, induced by external
structural perturbations [9–13]. Furthermore, PDA also exhibits
interesting ﬂuorescence properties; no ﬂuorescence is emitted by
the initially polymerized blue-phase PDA, while the red-phase PDA
strongly ﬂuoresces at 560 nm and at 640 nm (excitation at 485 nm)
[14]. The chromatic transformations of PDA have been exploited also in
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transitions could be induced by membrane-active compounds in
vesicle assemblies of phospholipid bilayers incorporated within the
PDA matrixes [15,16]. In the case of PDA-labeled living cells, we have
demonstrated that local disruptions within the plasma membrane
induce chromatic transformations of membrane-attached PDA
patches, thus making the modiﬁed cells an effective “live cell sensor”
for analysis of membrane processes.
Here we present a biophysical and physiological analysis of PDA-
labeled cells, aiming to elucidate the parameters contributing to
membrane incorporation of the lipid/diacetylene vesicles and the
physiological consequences of cell labelingwith PDA. The fundamental
questions we address in this study concern the extent of modiﬁcations
of the plasmamembrane environment following PDA labeling, and the
effect of cell-surface modiﬁcation upon crucial intracellular processes.
Several bioanalytical techniques and physiological assays have been
applied, providing a comprehensive description of lipid/diacetylene
vesicle fusion and the resultant modiﬁed cells, overall indicating that
the polymer patches do not adversely and signiﬁcantly affect cell
properties. Depicting the practical utilization of the PDA-labeled cell
platform,we applied the assay for distinguishingmechanisms of drug–
membrane interactions.
2. Materials and methods
2.1. Materials
Lipids, including 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE), 1,2-
dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt) (DMPG), 1,2-dimyr-
istoyl-sn-glycero-3-phosphocholine (DMPC), sphingomyelin (egg, chicken) (Sph), and
cholesterol (Chol) were purchased from Avanti Polar Lipids, Inc (Alabaster, AL). The
diacetylenic monomer 10,12-tricosadiynoic acid was purchased from Alfa Aesar
(Karlsruhe, Germany), washed in chloroform, and passed through a 0.45 μm nylon
ﬁlter prior to use.
Theﬂuorescent dyes 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-
2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD-PE) and 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rdh-PE)
were purchased from Avanti Polar Lipids, Inc (Alabaster, AL). 1-(4-trimethylammonium-
phenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH), Fura-2AM (acetoxymethyl ester), and
5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1) were
obtained from Molecular Probes, Inc. (Eugene, Oregon).
Tris[hydroxymethyl]aminomethane (Tris-base buffer), sodium dithionite, 2,4-dinitro-
phenol (DNP), methyl-β-cyclodextrin (MBCD), fMLP (fMet-Leu-Phe), probenecid, and
DMSO were purchased from Sigma-Aldrich. The CellTiter 96® AQueous One Solution Cell
Proliferation Assay (MTS) was purchased from Promega Corporation (Madison, WI, USA).
The pharmaceutical substances imipramine hydrochloride, amitriptyline hydrochloride,
nortriptyline hydrochloride, acebutolol hydrochloride, (±)-metoprolol (+)-tartrate salt,
procainamide hydrochloride, and diclofenac sodium salt were purchased from Sigma-
Aldrich.
2.2. Vesicle preparation
Preparation of vesicles containing the diacetylene monomer 10,12-tricosadiynoic
acid and the lipid components (DMPC/diacetylene — 2:3 mole ratio, DMPE/DMPG/
diacetylene — 1:1:3, Sph/chol/diacetylene — 1:1:3, DMPC/chol/diacetylene— 1.5:0.5:3)
was carried out through the following protocol: all vesicle constituents were dissolved
in chloroform/ethanol (1:1) and dried together in vacuo up to constant weight, followed
by addition of deionized water to ﬁnal concentration of 1 mM, and subsequently probe
sonicated at 70 °C for 3 min. The vesicle solution was then cooled at room temperature
and was kept at 4 °C.
2.3. Cell culture
Human promyelocytic leukemia cells HL-60 were grown in RPMI-1640 medium
supplementedwith 10% (v/v) heat-inactivated fetal calf serum, 2mML-glutamine, 50U/ml
penicillin and 50 μg/ml streptomycin in a humidiﬁed 5% CO2 atmosphere at 37 °C. The cell
lines were maintained at a density of 0.7–1×106 cells/ml before harvested and were sub-
cultured three times weekly.
2.4. Cholesterol depletion by methyl-β-cyclodextrin treatment
HL-60 cells were washed and incubated in HEPES buffer (1×106 cells/ml, pH 7.4)
containing 10mMmethyl-β-cyclodextrin (MBCD) for 1 h at 37 °C; following incubation,
the cells werewashed three timeswith the buffer and labeledwith the lipid/diacetylene
vesicles.2.5. Vesicle fusion with cells
Cells were harvested from the growth medium and washed in a HEPES buffer
(20 mM HEPES, 137 mMNaCl, 2.7 mM KCl, 1 mM KH2PO4, 2 mM L-glutamine, and 5 mM
D-glucose (pH 7.4)) by centrifugation at 400 g for 7 min. 2×106 cells per sample were
kept in 2 ml buffer to which the different lipid/diacetylene vesicles were added (ﬁnal
lipid concentrations 0.1–0.7 mM, depending on the experiment) and incubated for
45minwith slow shaking. Following incubation the cell suspensions were irradiated for
20–30 s at 254 nm (30–50 mJ/cm2) to polymerize the polydiacetylene backbone,
resulting in the appearance of blue color. The vesicle/cell hybrids were washed three
times for removal of non-associated vesicles and re-suspended in the same buffer
before experiments. All experimental steps were carried out at 25 °C.
2.6. Fluorescence resonance energy transfer (FRET)
Lipid/diacetylene vesicles (concentration 1 mM) were prepared by the
procedure described above. Prior to drying, the lipid/diacetylene vesicles were
additionally supplemented with N-NBD-PE and N-Rh-PE at a 100:1:1 (phospholipid:
N-NBD-PE:N-Rh-PE) mole ratio. Fluorescence emission spectra were acquired
(excitation 469 nm) in the range of 500–700 nm on a FL920 spectroﬂuorimeter
(Edinburgh, UK), using a 1 cm optical path cell. Three ratios of ﬂuorescence emission
peaks were recorded for each sample: Ri (initial)— ratio of ﬂuorescence emissions of
N-NBD-PE (530 nm)/N-Rh-PE (585 nm) immediately after cell and vesicle mixing, Rf
(ﬁnal) — after 45 min incubation with cells, and Rt — following the addition of 10%
Triton X-100 to the vesicles (Triton X-100 is a detergent causing vesicle destruction
and maximum dispersion of the ﬂuorescent dyes). The percentage of fusion was
determined by the equation [17]:
kFusion ¼ Rf  Rið Þ= Rt Rið Þ½ 4100:
All experiments were performed three times at 25 °C.
2.7. Fluorescence quenching
HL60 cells labeledwith theﬂuorescent dyeNBD-PEwere prepared as follows: NBD-PE
was dissolved in chloroform and dried prior to dissolution in absolute ethanol (1 mM). An
aliquot of the NBD-PE/ethanol solution (1% v/v) was injected into a cell suspension
containing 2×106 cells in 1ml cold HEPES buffer (pH 7.4) under vigorous stirring and kept
on ice for 30 min (ﬁnal concentration of NBD-PE 2 μM). The cells were subsequently
washed three times by centrifugation for removal of excess NBD-PE and re-suspended in
HEPES buffer. Lipid/diacetylene vesicle fusion was then carried out as described above.
The ﬂuorescence quenching reactionwas initiated by addition of sodium dithionite
from a 0.6 M stock solution prepared in 50 mM Tris-base buffer (pH 11) to a ﬁnal
concentration of 10 mM. The decrease in ﬂuorescence (467 nm excitation, 530 nm
emission) was recorded for 240 s at 25 °C on an Edinburgh FL920 spectroﬂuorimeter.
2.8. Fluorescence anisotropy
The ﬂuorescence probe TMA-DPH was incorporated into the cell membrane by adding
thedyedissolved inTHF (1mM) to cell suspension inHEPESbufferup toaﬁnal concentration
of 1.25 μM. After 30 min of incubation at 37 °C with gentle stirring the cell samples were
washed three times with HEPES buffer for removal of excess ﬂuorescent probe. Lipid/
diacetylene vesicles were then added to the cell suspension and incubated for 30 min at
37 °C. During all stages of preparation the cell density was 2×106 cells per 1 ml buffer.
DPH ﬂuorescence anisotropy was measured at 428 nm (excitation 360 nm) on an
Edinburgh FL920 spectroﬂuorimeter. Anisotropy values (r) were automatically
calculated by the spectroﬂuorimeter software using conventional methodology [18].
Fluorescence anisotropy measurements were performed at least three times.
2.9. Viability and cell proliferation
The cytotoxicity of the lipid/diacetylene vesicles has been assessed using a cell
proliferation assay (Promega CellTiter 96® AQueous One Solution Cell Proliferation
assay) [19]. Brieﬂy, 7×104 exponentially growing cells were seeded in 96-well
microculture plates together with the vesicles (ﬁnal concentration 0.1 mM) in volumes
of 100 μl. Immediately, and after 24 h incubation at 37 °C, 20 μl aliquots of 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazo-
lium, inner salt (MTS) were added to each well and the samples were incubated for
another hour at 37 °C. Plates were analyzed on a Jena Analytical ELISA reader at 490 nm.
For each type of vesicles at least 3 replicates were analyzed.
Cell counts in the tested sampleswere based upon a calibration curve, inwhich 2×104,
4×104,10×104, and20×104 cellswere seeded ina96-wellmicrocultureplate involumesof
100 μl. 20 μl MTSwas added to eachwell and the sampleswere incubated for a 1 h at 37 °C.
The plates were then analyzed on a Jena Analytical ELISA reader at 490 nm.
2.10. Cytosolic Ca2+ measurements
Measurements were carried out on differentiated HL60 cells. To induce granulocyte-
like cell differentiation, HL60 cells at a density of 4×104 cells/ml were cultured in the
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total cell count, as determined by the CD14 and CD11b differentiation markers (data not
shown). Differentiated cells were harvested from the medium, washed in HEPES buffer,
fused with the lipid/diacetylene vesicles and polymerized (see 2.5:vesicle fusion protocol
above). The PDA-labeled cells (as well as control untreated differentiated cells) were then
washed and re-suspended in Ca2+-buffer [137mMNaCl, 2.7 mMKCl, 20mMHEPES,1mM
KH2PO4,1mMMgCl2, 2mMCaCl2, 5mMD-glucose, 2.5mMprobenecid, 0.1% BSA (pH7.4)]
and incubatedwith 2 μMFura-2 AMdissolved in DMSO at 37 °C in the dark for 0.5 h under
gentle shaking. Cells were extracted at distinct times, washed twice with buffer and re-
suspended in the same Ca2+-buffer. After additional 15 min of stabilization the cells were
centrifuged and re-suspended in the same buffer at a concentration of 1×106 cells/ml.
Cytosolic Ca2+ concentration was determined through recording the changes in
Fura-2AM ﬂuorescence using a Perkin Elmer LS 50 S luminescence spectrometer.
Aliquots of 2×105 cells (200 μl) per 2 ml of Ca2+-buffer without BSA and probenecid
were transferred to a temperature-controlled (25 °C) cuvette under continuous stirring.
Excitations at 340 and 380 nmwere recorded at a ﬁxed emission (510 nm). At the end of
each experiment the cells were lysed through addition of 0.1% Triton X-100 and
supplemented by 20 mM EGTA to obtain the maximal and minimal Ca2+ levels, respec-
tively. Calcium concentration was calculated by the equation [21]:
Ca2þ
h i
i
¼ Kd R Rminð Þ= Rmax  Rð Þ;
where Rmin and Rmax are the Fura-2AM ﬂuorescence excitation ratios at 340/380 nm for
Ca2+-lacking and Ca2+-saturation concentrations, respectively. Kd for the Fura-2AM–Ca2+
complex was taken as 224 nM [21].
2.11. Mitochondria membrane potential
The ﬂuorescent dye JC-1 was dissolved in DMSO to give a 5 mg/ml stock solution.
This was further diluted 1/2000 in HEPES buffer and ﬁltered using a 0.45-μm ﬁlter
(Whatman). To assess the effect of PDA labeling on mitochondrial inner membrane
potential, 50 μl of the labeled cell suspension containing 2×106 cells were extracted and
incubated for 30min at 25 °Cwith 500 μl of theﬁltered JC-1working solution (2.5 μg/ml).
Cells were washed three times with HEPES buffer, deposited on a cover-slip and
analyzed after PDA labeling at distinct time periods by ﬂuorescent microscopy (Perkin
Elmer's spinning disc system: Ultra View ERS Rapid Confocal Imager). Unlabeled cells
were washed with HEPES buffer and used as control. For comparison, both PDA-labeled
cells and untreated cells after staining with JC-1 were incubated for 10minwith 0.5 mM
DNP, a mitochondrial membrane uncoupling agent. Brieﬂy, 1 μg of DNP was dissolved in
20 μl DMSO, this was further diluted 200 times in HEPES buffer (total concentration
1 mM) and was added to equal volumes of the cell suspension.
To view J-aggregates, excitation was 488 nm and green emission discrimination
ﬁlter was used (498–552 nm); for monomeric JC-1, emitted light was collected through
a red band-pass 580 nm to 615 nm ﬁlter (excitation 514 nm). A pseudo-color value was
assigned to the acquisition of the red/green ratio and analyzed with Volocity™ 3-D/4-D
visualization and analysis software. For each cover-slip three images of each condition
were analyzed, and the intensity of the red/green ﬂuorescence ratio signal from at least
10 cells in each image was determined.
2.12. Colorimetric analysis
Quantitative colorimetric determination was applied to cells labeled with DMPE/
DMPG/diacetylene vesicles and polymerized (see preparation procedure above).Fig. 1. Cell labeling with lipid/PDA patches. A. Cells (top) incubated with lipid/diacetylene ves
attached to the cell surface; B. irradiationwith UV light induces polymerization of the diacetyle
transformation of PDA.Samples were prepared by adding the pharmaceutical compound examined, dissolved
in water, to a 60 μl HEPES buffer (pH 7.4) solution containing 2×106 labeled cells.
Following addition, the solutions were diluted to 1ml and UV-Vis spectrawere acquired
at 25 °C on a Jasco V-550 spectrophotometer, using a 1 cm optical path cell. The
measurements were repeated three times for each sample.
A quantitative value for the extent of the blue-to-red color transitions within the
PDA-labeled solutions is given by the colorimetric response (%CR), which is deﬁned as
follows [16]:
kCR ¼ PB0  PBIð Þ=PB0Þ  100;
where PB=Ablue/(Ablue+Ared), A is the absorbance either at the “blue” component in the
UV-Vis spectrum (640 nm) or at the “red” component (540 nm) (note: “blue” and “red”
refer to the visual appearance of the material, not its actual absorbance). PB0 is the blue/
red ratio of the control sample (before addition of the pharmaceutical compounds), and
PBI is the value obtained for the PDA-labeled cells solution after induction of color
change.
Further colorimetric analysis was carried out to compare the induced transitions in
the PDA-labeled cells to the color transformations in cell-free DMPE/DMPG/PDA
vesicles (1:1:3 mole ratio). Final lipid concentration of the vesicles was 0.7 mM. The
vesicles were pre-incubated in HEPES buffer for 45 min prior to polymerization (for
mimicking the preparation protocol of the PDA-labeled cells). The vesicle solution was
diluted to insure that the initial intensity of the “blue” component in the UV-Vis
spectrum (peak at 640 nm) of the vesicle sample (before addition of the pharmaceutical
compounds) was identical to the corresponding signal in the PDA-labeled cells.
2.13. Fluorescence microscopy
Microscopy analysis was conducted for evaluating the effect of pharmaceutical
compounds upon the PDA-labeled HL60 cells. Samples were prepared according to the
procedure described above (colorimetric analysis) with minor changes: following
addition of the pharmaceutical compounds, the solutions were diluted to 200 μl, from
which 20 μl were deposited onto glass cover-slips. Fluorescence images of the PDA-
labeled cells were acquired on a laser-scanning confocal microscope Axiovert-100 M
(Zeiss, Germany) with a Plan-Neoﬂuar 100×/1.3 oil objective. Excitation was 488 nm
using an argon laser source. Emitted light was collected through a band-pass 625–
655 nm ﬁlter.
3. Results
3.1. Biophysical characterization
Fig.1 schematically depicts the procedure formembrane labeling of
living cellswith chromatic polymer patches [6]. The cells are incubated
in a buffer solution containing vesicles comprising the diacetylene
monomers and lipids (Fig.1A). Subsequently, the lipid/diacetylene/cell
constructs are polymerized through brief irradiation with UV light
(254 nm), resulting in the creation of the chromatic sensor cells
(Fig.1B). Thepolymer patches attached to the cell surface undergo both
blue–red transformations as well as emit intense ﬂuorescence in re-
sponse to processes occurring upon, or affecting the plasmamembraneicles (lipids depicted in yellow, diacetylene monomers in black), resulting in the vesicles
ne monomers; C. interactionwith membrane-active compounds give rise to the blue–red
Fig. 2. Fusion of lipid/diacetylene vesicles with the plasma membrane. Percentage fusion calculated through the FRET experiments: A. different lipid compositions: i. DMPE/DMPG/
diacetylene (1:1:3 mole ratio); ii. DMPC/chol/diacetylene (1:1:3); iii. Sph/chol/diacetylene (1:1:3); and iv. DMPC/diacetylene (1:1.5). B. effect of cholesterol extraction: i. cells treated
with cyclodextrin; and ii. untreated cells. Percentage fusion ratios were calculated with respect to the effect of Triton X-100 (taken as 100%).
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properties of the engineered cells [6,7]. In the experiments depicted
in this workwe have employed HL60 cells, awidely-used leukemic cell
line [22].
Fluorescence resonance energy transfer (FRET) experiments were
carriedout to evaluate theextentof fusionbetween the lipid/diacetylene
vesicles and the plasma membrane of the cells, and the dependence of
fusion upon lipid composition (Fig. 2). The FRETanalysis employed lipid/
diacetylene vesicles with different lipid compositions, which further
contained the ﬂuorescently-labeled phospholipids NBD-PE and rhoda-
mine (Rh)-PE (seeMaterials andmethods). FRETanalyses of vesicle–cells
fusion rely on the fact that prior to vesicle–cell interactions efﬁcient
ﬂuorescence energy transfer occurs between the vesicle-incorporated
NBD (ﬂuorescence donor) and Rh (ﬂuorescence acceptor) [17]. However
in the event of membrane fusion (with consequent lipid mixing among
the vesicle and cellmembrane bilayers) theﬂuorescence energy transfer
is reduced due to the greater distance, on average, between the donor
and acceptor molecules within the fused system [17].
Fig. 2A examines the extent of lipid fusion following incubation of
the lipid/diacetylene vesicles with the HL60 cells, and the dependence
of fusion upon speciﬁc vesicle compositions. The percentage values
reported in Fig. 2Awere derived from the ratios between the emission
peaks of the donor (530 nm) and acceptor (585 nm), respectively,
following incubation of vesicles and cells. Themaximal donor/acceptor
ratio is referred to Triton X-100 which induces complete dissolution of
the vesicles, and thus minimal energy transfer between donor and
acceptor [23]. The bar diagram in Fig. 2A clearly demonstrates that the
most pronounced fusion occurred when DMPE/DMPG/diacetylene
vesicles were incubated with the cells. In contrast, vesicles containing
DMPC, DMPC/cholesterol, or sphingomyelin/cholesterol all exhibited
signiﬁcantly lower fusion values (Fig. 2A).
In addition to illuminating the relationship between membrane
fusion and lipid composition of the vesicles, we also investigated
the contributions of speciﬁc lipid components of the plasma cell
membrane upon vesicle fusion (Fig. 2B). Speciﬁcally, the experiment
depicted in Fig. 2B was designed to examine the role of cholesterol
within the plasma membrane in promoting vesicle fusion. Fig. 2B
compares the extent of fusion of DMPE/DMPG/diacetylene vesicles to
normal HL60 cells (determined through FRET analysis), to vesicle
fusion with HL60 cells pre-incubated with methyl-β-cyclodextrin
(MBCD), known to extract cholesterol from the plasma membrane of
cells [24]. Indeed, the bar diagram in Fig. 2B clearly indicates that
cholesterol removal from the cell membrane signiﬁcantly reduced
fusion (from 50% to approximately 25%).
Application of other biophysical techniques complemented the FRET
data in Fig. 2 and provided additional insight into the interactions and
incorporation of the lipid/diacetylene vesicleswithin the cellmembrane
(Fig. 3). Fig. 3A depicts the results of ﬂuorescence quenching analysis[25] utilizing HL60 cells incorporating the NBD-PE dye within the
plasma membrane, and further incubated with lipid/diacetylene vesi-
cles. In the experiments summarized in Fig. 3A, the ﬂuorescence
quencher sodiumdithionitewas added to theNBD-PE/lipid/diacetylene/
HL60 constructs and the NBD ﬂuorescence was monitored over time.
The emission curves in Fig. 3A display the expected exponential
quenching of the NBD ﬂuorescence following interactions with the
water-soluble dithionite. However, differences were observed among
the rates of ﬂuorescence quenching when different vesicles were
incubated with the cells. These differences correspond to the relative
exposure of the NBD residues to the aqueous solution — thus to the
dissolved dithionite quencher [25]. In particular, the fastest quenching
rate was recorded following addition of DMPE/DMPG/diacetylene to
the NBD-PE/HL60 cells (curve iv in Fig. 3A). This result is most likely
explained by the pronounced lipid rearrangement within the plasma
membrane following interactions with the DMPE/DMPG/diacetylene
vesicles, facilitating greater contact between the membrane-
embedded NBD-PE and the dithionite. The pronounced ﬂuorescence
quenching following DMPE/DMPG/diacetylene vesicle addition, in
comparison with the other lipid compositions examined, echoes
the signiﬁcant fusion between these vesicles and the cell membrane
(Fig. 2A).
Fluorescence anisotropy measurements depicted in Fig. 3B and C
shedmore light on the dynamical consequences of vesicle interactions
with the plasma membrane of the HL60 cells. The experiments in
Fig. 3B–C employed HL60 cells containing the ﬂuorescence dye TMA-
DPH. The bar diagrams in Fig. 3B and C display the ﬂuorescence aniso-
tropy of TMA-DPH pre-incubated with the HL60 cells prior to addition
of the lipid/diacetylene vesicles, and subsequent modiﬁcations of bi-
layer order induced by vesicle interactions. Indeed, the ﬂuorescence
anisotropyof lipid-embedded TMA-DPH,which is located in the bilayer
close to the lipid/water interface, has been widely used as a probe of
lipid acyl chain order and lateral diffusion within lipid bilayers [26].
Fig. 3B illuminates the changes of the ﬂuorescence anisotropy of
TMA-DPH induced by interactions of the cell plasma membrane with
vesicles having different lipid constituents. Fig. 3B demonstrates that
most lipid compositions yielded higher anisotropy — indicating
increased rigidity of the membrane bilayer, most likely due to binding
of the vesicles to the surface of the plasma membrane. Signiﬁcantly,
the most pronounced effect – highest ﬂuorescence anisotropy – was
observed after DMPE/DMPG/diacetylene vesicles were incubated with
the cells (Fig. 3B, iv). The induction of highest bilayer rigidity following
addition of DMPE/DMPG/diacetylene vesicles is most likely a
consequence of the efﬁcient vesicle/cell fusion, and is consistent
with the experimental data presented in Figs. 2 and 3A.
Fig. 3C depicts the results of a titration experiment in which the
TMA-DPH ﬂuorescence anisotropy was recorded in solutions contain-
ing different concentrations of DMPE/DMPG/diacetylene vesicles.
Fig. 4. Cell viability. Cell proliferation results obtained using CellTiter 96® AQueous One
Solution Cell Proliferation assay [19]. i. HL60 cells labeled with DMPE/DMPG/diacetylene
vesicles; ii. Untreated (control) cells. White bar: immediately after mixing the cells with
vesicles (vesicle buffer in caseof control cells);Grey bar: after 24 h incubationwith vesicles.
Fig. 3. Effect of lipid/diacetylene vesicles on lipid organization in the plasmamembrane. A.ﬂuorescence quenching experiments:ﬂuorescence decays ofmembrane-incorporatedNBD-
PE induced by sodium dithionite added to HL60 cells incubated with: i. DMPC/diacetylene (1:1.5); ii. DMPC/chol/diacetylene (1:1:3); iii. Sph/chol/diacetylene (1:1:3); and iv. DMPE/
DMPG/diacetylene (1:1:3mole ratio). Theﬂuorescence decay is reported as a percentage of the initialﬂuorescencemeasured before addition of dithionite. B.ﬂuorescence anisotropyof
membrane-incorporated DPH-TMA after incubation of the cells with: i. DMPC/diacetylene (1:1.5); ii. DMPC/chol/diacetylene (1:1:3); iii. Sph/chol/diacetylene (1:1:3); and iv. DMPE/
DMPG/diacetylene (1:1:3 mole ratio). C. ﬂuorescence anisotropy of membrane-incorporated DPH-TMA following addition of different concentrations of DMPE/DMPG/diacetylene
vesicles to the cells.
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embedded TMA-DPH gradually increases in the presence of greater
vesicle concentrations, conﬁrming the direct relationship between
the induced bilayer rigidity and vesicle interactions with the plasma
membrane.
3.2. Physiology of PDA-labeled cells
While Figs. 2 and 3 indicate that the fusion of the lipid/PDAvesicles
onto the cell surface affect the molecular properties of the plasma
membrane, the experiments do not provide insight into the overall
physiological effects on the modiﬁed cells. Accordingly, Figs. 4–6
present application of biological assays designed to evaluate the effect
of membrane labeling with PDA upon cell viability, and upon phyio-
logical processes occurring in the cell interior.
The bar diagram in Fig. 4 depicts the results of an MTS-based cell
proliferation assay designed to determine the effect of incubationwith
the DMPE/DMPG/diacetylene vesicles upon overall cell viability. Live
cell counting was carried out immediately after lipid/diacetylene
vesicle addition (white bars in Fig. 4) and following 24 h incubation
(grey bars). The data presented in Fig. 4 clearly show that the relative
increase in the number of cells in the solution containing lipid/
diacetylene vesicles was similar to the control cells (to which vesicles
were not added). This proliferation is an indication of a vital cell
population that kept dividing even through incubation and fusion of
the lipid/diacetylene vesicles to the plasma membrane.
In addition to the overall viability and normal proliferation of the
surface-labeledHL60 cells (Fig. 4),we investigated the effects of vesicle
treatment upon important intracellular cell processes. Fig. 5 depictsan in situ analysis of changes in cytosolic Ca2+ in PDA-labeled and
unlabeled differentiated HL60 cells (dHL60). The differentiation of
HL60 cells to granulocytes is important, since only the differentiated
cells can be rapidly activated through plasmamembrane receptors and
intracellular Ca+2 stores that trigger responses to chemotactic factors
such as N-formyl-methionyl-leucyl-phenylalanine (fMLP) [27]. The
experiment depicted in Fig. 5 monitors the high sensitivity of cytosolic
Fig. 5. Cytosolic calcium concentration ([Ca2+]i) in PDA-labeled cells. fMLP-triggered
intracellular-calcium concentrations determined by the ﬂuorescent dye Fura-2AM.
A. representative experiment depicting the increase in [Ca2+]i induced by addition of
fMLP to control cells (a), andPDA-labeled cells (b). B. percentageof fMLP-triggered [Ca2+]i in
PDA-labeled cells vs. untreated (control) cells (determined at themaximumvalue of [Ca2+]i
in A, calculated at different time-points after polymerization of the cell surface-attached
DMPE/DMPG/diacetylene patches.
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chemotactic peptide fMLP. This peptide is known to increase the
concentration of intracellular Ca2+ ([Ca2+]i), which is mobilized from
both intracellular stores and by uptake from extracellular sources [28].
Cytosolic Ca2+ concentration ([Ca2+]i), was assessed using the ﬂuo-
rescent calcium indicator Fura-2AM [29]. Determination of [Ca2+]i was
performed after cell incubation with DMPE/DMPG/diacetylene vesicles
and further polymerization through brief irradiation at 254 nm. Fig. 5A
demonstrates that following activation by 1 μM fMLP, both untreatedFig. 6. Mitochondria membrane potential in HL60 cells. Fluorescence images of the JC-1
polymerization; C. HL60 cells treated with DNP (mitochondrial membrane depolarizer).(control) cells, as well as the PDA-labeled cells exhibited elevated levels
of free cytosolic Ca2+. Importantly, Fig. 5A shows that even though the
[Ca2+]i peak appeared somewhat reduced in the PDA-labeled cells (curve
b) compared to the untreated cells (curve a), the shape of the [Ca2+]i
curve was indicative of normal (functional) response of the calcium
storage cell machinery [29]. Furthermore, Fig. 5A suggests that most
fMLP membrane receptors retain their functionality even when PDA is
also loaded on the cell surface; the small difference between the [Ca2+]i
response in the PDA-labeled cells and control cells is probably due to the
lipid/PDA vesicle fusion onto the membrane. Fig. 5B further demon-
strates that the ratio between the [Ca2+]i peak following fMLP
stimulation in normal and in PDA-labeled cells remained almost
constant even 3 h after fusion and polymerization, indicating that this
fundamental signaling pathway is not disruptedwithin this time period.
Another important functional assay performed on the PDA-labeled
cells was a mitochondrial membrane potential analysis [30] (Fig. 6).
Fig. 6 depicts the ﬂuorescence emission images obtained using the
cationic lipophilic dye JC-1which selectively entermitochondria [30]. In
solution, free JC-1 exists in monomers emitting green ﬂuorescence
(excitation490nm, emission527nm),howeverwhen themitochondrial
membrane is functionally viable (polarized) the dye forms J-aggregates
(multimers) which exhibit a large shift in emission (590 nm, red–
orange). Thus, JC-1 ﬂuorescence is highly sensitive to mitochondria
membrane potential, changing from red to green upon events leading to
loss of mitochondrial transmembrane potential as a result of mitochon-
drial damage. Overall, the ratio of red (J-aggregate)/green (monomeric
JC-1) emission reﬂects the physiological state of mitochondria [31].
The representative ﬂuorescence microscopy images of the HL60
cells in Fig. 6 conﬁrm that no signiﬁcant membrane depolarization
occurred following PDA labeling. The image of the control (untreated)
cells (Fig. 6A) depicts the red ﬂuorescence from the J-aggregates
accumulated within the mitochondria. PDA-labeled cells feature
mainly red and yellow ﬂuorescence areas (Fig. 6B), indicative of
minimally disrupted mitochondrial membrane potential. The ﬂuores-
cence images in Fig. 6A–B stand in stark contrast to the microscopy
picture in Fig. 6C corresponding to completemitochondrial membrane
depolarization induced by 2,4-dinitrophenol (DNP) [32], resulting in
the appearance of only the green JC-1 monomers. The ﬂuorescence
data presented in Fig. 6 are consistent with the [Ca2+]i measurements
(Fig. 5), overall indicating that plasmamembrane labeling by the lipid/
PDA do not exert adverse effects upon cell physiology.
3.3. Practical applications
Fig. 7 depicts a representative application of the PDA-labeled cell
platform for analyzing membrane interactions of pharmaceutical
compounds (Table 1). Evaluation of bilayer association and membrane
permeation of pharmaceutical compounds is a critical component indye: A. control (untreated) cells; B. PDA-labeled cells 90 min after incubation and
Fig. 7. Interactions of pharmaceutical compounds with PDA-labeled HL60 cells. A. Transmission (top) and ﬂuorescence microscopy (bottom) images of PDA-labeled cells mixed with:
i. imipramine (0.06 mg/mL); ii. metoprolol (17 mg/mL); and iii. procainamide (15 mg/mL). B. Colorimetric dose–response curves of PDA-labeled cells mixed with: nortriptyline (ﬁlled
triangles), amitryptyline (ﬁlled circles), imipramine (ﬁlled diamonds), metoprolol (empty triangles), acebutolol (empty circles), diclofenac (empty squares), procainamide (x).
C. Colorimetric dose–response curves induced by imipramine (left) and metoprolol (right) in HL60 cells labeled with DMPE/DMPG/PDA (solid curve) and cell-free DMPE/DMPG/PDA
vesicles (broken curve).
Table 1
Physicochemical properties of the pharmaceutical compounds tested [33,35]
Compound Mw logD (pH 8)
1 Amitriptyline 313.9 4.89
2 Imipramine 316.9 2.97
3 Nortriptyline 299.8 3.61
4 Acebutolol 372.9 1.45
5 Metoprolol 684.8 0.59
6 Diclofenac 318.1 −0.35
7 Procainamide 271.8 −0.61
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lipid barriers, such as the blood-brain barrier (BBB) or the gastro-
intestinal tract (GI), which might signiﬁcantly affect drug delivery and
efﬁcacy [33]. Analysis of membrane interactions and permeation by
pharmaceutical molecules is generally carried out through application
of crude techniques, such as alcohol/water partition coefﬁcients, that
occasionally are not satisfactory as predictive tools.
Fig. 7A presents transmission and ﬂuorescence microscopy images
of PDA-labeled HL60 cells to which pharmaceutical compounds were
added. Imipramine (Fig. 7Ai) andmetoprolol (Fig. 7Aii) gave rise to the
appearance of ﬂuorescent spots on the cell surface; however meto-
prolol required an order-of-magnitude higher concentration for in-
duction of ﬂuorescence, compared to imipramine. Procainamide, on
the other hand, did not induce ﬂuorescence emission when added tothe PDA-labeled cells even at a high concentration (Fig. 7Aiii). The
ﬂuorescent spots appearing on the cell surface correspond to the
membrane-incorporated PDA patches undergoing the structural/
1342 N. Groysman et al. / Biochimica et Biophysica Acta 1778 (2008) 1335–1343chromatic transformation, induced through plasma membrane inter-
actions of the tested compounds [6].
The signiﬁcant differences in concentration-dependent ﬂuores-
cence induction in Fig. 7A reﬂect the distinct membrane afﬁnities and
bilayer disruption properties of the pharmaceutical compounds ex-
amined. Imipramine (Fig. 7Ai) binds strongly to lipid bilayers and is
believed to exhibit high afﬁnity to membrane bilayers [34], conse-
quently expected to induce signiﬁcant reorganization of the bilayer
surface and the corresponding chromatic transformations of the
membrane-fused PDA patches, as depicted in Fig. 7Ai. Metoprolol
(Fig. 7Aii) is a highly hydrophobic substance which inserts deeply into
membrane bilayers [35] thus requiring a higher concentration to
induce membrane perturbations and consequent chromatic transfor-
mation of PDA. In contrast to both imipramine and metoprolol, pro-
cainamide does not penetrate through lipid barriers through passive
diffusion mechanisms [36] and thus did not affect ﬂuorescence
changes of the membrane-attached PDA patches (Fig. 7Aiii).
Indeed, the concentration range in which the PDA chromatic
transformations are induced by a tested pharmaceutical compound
is an important parameter which can be ascribed to the mechanism of
membrane binding and permeation. This observation is further
exempliﬁed in Fig. 7B which features the color transformations of the
PDA-labeled cells. Essentially, Fig. 7B depicts the “colorimetric
response” (%CR) dose–response curves recorded for several pharma-
ceutical compounds added to the PDA-labeled cell suspensions. Data-
points in the graph in Fig. 7B were calculated from the relative
intensities of the blue and red peaks in the UV-Vis spectra of the PDA-
labeled cell suspensions (see Materials andmethods); high %CR values
correspond to stronger red appearance of the cells, while low %CR
reﬂects more blue color.
Fig. 7B indeed demonstrates that the color transformations of the
PDA-labeled cells were induced in considerably different concentra-
tion ranges [note the logarithmic scale of the x axis]. Speciﬁcally, while
imipramine, amitriptyline, and nortriptyline affected the blue–red
transitions of the PDA-labeled cells in concentrations which were
smaller than 0.1 mg/ml, metoprolol and acebutolol required signiﬁ-
cantly greater concentrations, of between 1 and 10 mg/ml. Fig. 7B also
shows that procainamide and diclofenac yielded negligible color
changes in the PDA-labeled cells, even when added in much higher
concentrations to the PDA-labeled cell solution.
The experiments depicted in Fig. 7C were designed to assess
whether the ﬂuorescence (Fig. 7A) and color transformations (Fig. 7B)
induced by the pharmaceutical compounds in the PDA-labeled cells
were due to actual interactions with the plasmamembrane of the cell,
or rather the chromatic transitions corresponded to non-speciﬁc
binding of the pharmaceutical compounds to the surface-attached PDA
patches. This distinction is important, because PDA chromatic
transitions induced by direct binding of the pharmaceutical sub-
stances will obviously be less informative from a biological point of
view [6].
Speciﬁcally, Fig. 7C compares the dose–response curves induced by
imipramine and by metoprolol in PDA-labeled cells and in cell-free
DMPE/DMPG/PDA vesicles, respectively. The blue signals in the PDA-
labeled cells and the lipid/PDA vesicles, respectively, were adjusted to
be of equal intensity, and accordingly the differences apparent in the
graphs between the colorimetric responses induced in the cells and in
the vesicles point to different mechanisms responsible for the color
transitions in each system. In particular, while imipramine induced
much more pronounced blue–red transitions in the lipid/PDA vesicles
compared to the PDA-labeled cells, the situation was the opposite for
metoprolol (higher %CR induced when added to PDA-labeled cells,
Fig. 7C). These results indicate that the chromatic transformations
induced by the pharmaceutical compounds in the PDA-labeled cells
originate from distinct interactions of the molecules with the plasma
membrane of the cells, which consequently affect the structural
transitions of the membrane-incorporated polymer patches.4. Discussion
We presented a detailed biophysical and physiological investiga-
tion of newly-designed polydiacetylene-labeled cells and their ap-
plication for studying membrane processes. A fundamental question
addressed in this study was the following: to what extent the chro-
matic polymer patches were indeed embedded within the plasma
membrane of the cells, and whether this cell-surface modiﬁcation
signiﬁcantly (and adversely) affected the membrane properties and
overall cell physiology.
The lipid components within the mixed lipid/diacetylene vesicles
were found to be a critical parameter determining the extent of fusion
with the cell plasma membrane. In particular, ﬂuorescence resonance
energy transfer (FRET) experiments depicted in Fig. 2 conﬁrmed the
occurrence of signiﬁcantly greater lipid fusion between DMPE/DMPG/
diacetylene vesicles (1:1:3 mole ratio) and the plasma membrane,
compared to other vesicle compositions. Enhanced fusion phenomena
in case of vesicles comprising phospholipids displaying the PE and PG
headgroups have been previously observed [37]. Similar observations
were also reported for other PDA-labeled cell systems [6]. Interest-
ingly, while cholesterol in the vesicles did not appear to enhance lipid
fusion (Fig. 2A), its presence within the cell membrane seems im-
portant (Fig. 2B). This result suggests that increased bilayer disorder
decrease fusion of the lipid/diacetylene vesicles to the plasma mem-
brane. The signiﬁcance of lipid ordering in affecting vesicle fusion has
been previously reported [38].
Application of additional biophysical techniques complemented
the FRET analysis and provided additional insight into the molecular
characteristics of vesicle–membrane interactions. Both the ﬂuores-
cence quenching (Fig. 3A) and ﬂuorescence anisotropy (Fig. 3B–C) data
indicate pronounced effect upon the cell membrane following inter-
actionswith the DMPE/DMPG/diacetylene vesicles. Similar to the FRET
results — DMPE/DMPG/diacetylene vesicles gave rise to much more
signiﬁcant effects compared to the other lipid compositions examined:
marked lipid rearrangement (implied by the quenching experiments,
Fig. 3A) and lesser lateral diffusion (TMA-DPH anisotropy, Fig. 3B–C).
Both scenarios are consistent with a considerable lipid mixing be-
tween the DMPE/DMPG/diacetylene vesicles and the plasma mem-
brane bilayers.
A crucial question pertaining to the usefulness of the new PDA–cell
system for probing membrane processes in living cells concerns the
effect of vesicle fusion on cell vitality and normal cell physiology. Cell
viability assays (Fig. 4), clearly show that HL60 cells incubated with
DMPE/DMPG/diacetylene vesicles continued to proliferate at a rate
that was similar to untreated cells even after 24 h incubationwith the
lipid/diacetylene vesicles.
Physiological assays focusing on speciﬁc cell pathways conﬁrmed
that lipid/diacetylene labeling of the cell membrane had aminor effect
on fundamental cellular processes. In that regard, the cytosolic Ca2+
stimulation experiment depicted in Fig. 5 underlies two important
aspects pertaining to the PDA-labeled HL60 cells. First, intracellular-
calcium release triggered by extracellular ligands such as fMLPwas not
adversely affected in PDA-labeled cells. Second, the data in Fig. 5
suggests that attachment and polymerization of the lipid/PDA vesicles
onto the cell surface did not signiﬁcantly restricted access to the
cognate receptors of fMLP — further indications for the minimal
functional consequences of PDA labeling. Mitochondrial membrane
potential measurements shown in Fig. 6 further illuminated the
downstream effects of lipid/diacetylene fusion and polymerization,
demonstrating that viability of the mitochondria was retained more
than 90min after irradiation of the cells to induce PDA polymerization.
The chromatic cellmembrane assay can be employed for inspection
and analysis of variedmembrane processes, either by taking advantage
of the intense ﬂuorescence emission of the red-phase PDA patches for
ﬂuorescence microscopy analysis, or through UV-Vis spectroscopic
examination based upon the blue–red transformations of the polymer.
1343N. Groysman et al. / Biochimica et Biophysica Acta 1778 (2008) 1335–1343A representative example is given in Fig. 7 which depicts the appli-
cation of the chromatic cells for detection of membrane interactions of
pharmaceutical compounds. Indeed, the microscopic and spectro-
scopic experiments summarized in Fig. 7 reveal a close relationship
between the bilayer afﬁnity and insertion of the compounds examined
and the induced ﬂuorescence/color changes.
Speciﬁcally, amphiphilic molecules that exhibit high afﬁnity to
membrane bilayers induce chromatic transitions of the membrane-
attached PDA patches at signiﬁcantly lower concentrations compared
to hydrophobic compounds like metoprolol and acebutolol. In
contrast, pharmaceutical substances which exhibit negligible mem-
brane interactions (or which do not permeate the plasma membrane
through passive diffusion mechanisms) — do not induce chromatic
transformations of the attached PDA. Indeed, the chromatic response
of the PDA-labeled cell assay can be roughly divided between these
three groupings as depicted in Fig. 7B. The %CR curves in Fig. 7B
highlight the potential application of the chromatic cells to distinguish
among the membrane interaction proﬁles of tested compounds.
Importantly, the application of the PDA-labeled cell platform does not
require, a priori, knowledge on partition coefﬁcients or binding con-
stants of compounds tested. The relative ease of constructing the PDA-
labeled cells and the fast chromatic response obtained (few seconds
after mixing the cells and compound to be examined) point to the
potential use of the cells in high throughput screening formats.
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